Given its relative simplicity and low cost, immunohistochemical evaluation of MMP-11 expression in tumor tissues offers a complementary prognostication tool, allowing for a more nuanced risk assessment, tailored follow-up of these early, hormone receptors positive, breast tumors. Here, MMP11 is linked to neoplasm.